We would like to direct your attention to this wonderful article by Mr. Ruedi Küng on the research partnership between Allan Buzibye and Daniel Müller.
The article was published on UZH news ahead of the upcoming “Dialogue Days 2019”.
R4GH team members share their personal insights with interested readers in the Personal Insights Blog.
The ALPHA Study
Amikacin Exposure and Toxicity – Pharmacokinetic Pharmacodynamic Analysis in Patients with Multidrug-Resistant Tuberculosis in Uganda : A Pilot Study Treatment of patients with multidrug-resistant TB...
Species Identification of Non-Tuberculous Mycobacteria in the Ugandan Population
Infections with non-tuberculous mycobacteria (NTM) are on the rise worldwide, directing the global focus to these lesser known organisms. NTM range from harmless microbes to...
Gestational diabetes mellitus in HIV-infected women
Diabetes mellitus (DM) is one of the most common non-communicable diseases worldwide. The number of people with diabetes is increasing rapidly, especially in sub-Saharan Africa....